summari
woman
present
emerg
room
local
hospit
pleurit
chest
pain
regularli
work
admit
take
performanceenhanc
drug
ped
clinic
find
diagnost
work
reveal
diagnosi
perimyocard
adequ
therapi
initi
cours
first
day
patient
intub
mechan
ventil
diagnosi
bilater
pneumonia
acut
respiratori
distress
syndrom
ard
due
infect
rhinoviru
spp
made
smoke
habit
intens
physic
train
use
ped
may
exacerb
cours
viral
pneumonia
day
patient
could
extub
length
stay
intens
care
unit
day
hospit
discharg
patient
went
pulmonari
rehabilit
facil
week
outcom
favour
patient
resum
strength
endur
train
prolong
use
anabolicandrogen
steroid
aa
associ
endocrin
cardiovascular
immunolog
side
effect
fatal
outcom
includ
sudden
cardiac
death
report
aa
abus
increas
risk
advers
outcom
patient
need
gener
anaesthesia
well
known
extend
preoper
work
differ
ventil
set
cautiou
use
muscl
relax
differ
dose
anaesthet
agent
advis
improv
periop
outcom
howev
recommend
exist
emerg
depart
intern
surgic
ward
health
risk
selfadminist
cocktail
performanceenhanc
drug
ped
larg
unknown
often
unrecognis
increas
preval
substanc
abus
due
easi
access
potenti
fatal
consequ
reinforc
need
heighten
awar
among
healthcar
provid
ped
may
increas
risk
infect
low
virul
virus
rhinoviru
may
caus
substanti
morbid
patient
consid
potenti
immunosuppress
woman
present
emerg
room
local
hospit
pleurit
chest
pain
short
breath
symptom
start
suddenli
car
drive
last
h
ibuprofen
allevi
pain
mild
upper
respiratori
tract
infect
start
day
previous
appar
get
wors
special
diet
eaten
littl
taken
small
amount
drink
past
sever
day
known
medic
condit
initi
deni
regular
intak
medic
smoke
cigarett
use
recreat
drug
inquiri
patient
regularli
work
admit
take
thyroid
hormon
liothyronin
levothyroxin
oestrogenantagonist
anastrozol
anabol
steroid
dehydrochlormethyltestosteron
stanozolol
sympathomimet
drug
clenbuterol
insulinlik
growth
factor
diuret
aldacton
torasemid
muscl
buildup
perform
enhanc
howev
exact
dose
durat
intak
ped
could
determin
patient
use
hormon
contracept
vagin
ring
admiss
patient
puls
rate
bpm
blood
pressur
mm
hg
bodi
temperatur
oxygen
satur
measur
transcutan
breath
room
air
neck
vein
flat
examin
supin
posit
consist
extracellular
volum
deficit
faint
bilater
basal
crackl
suggest
lower
respiratori
tract
infect
moreov
patient
diffus
epigastr
pain
palpat
clitori
hypertrophi
laboratori
test
show
increas
marker
inflamm
c
reactiv
protein
mgl
normal
mgl
leucocyt
gl
normal
gl
mild
rel
monocytosi
normal
liver
enzym
slightli
elev
aspart
transaminas
ast
ul
normal
ul
alanin
transaminas
alt
ul
normal
ul
cardiac
enzym
increas
troponin
mgl
normal
mgl
creatin
kinas
ul
normal
ul
haemoglobin
concentr
admiss
gl
normal
gl
haematocrit
normal
initi
chest
xray
reveal
abnorm
lung
parenchyma
sign
pulmonari
congest
figur
ddimer
within
normal
limit
suggest
low
probabl
pulmonari
embol
histori
preced
common
cold
typic
find
ecg
posit
spodick
sign
small
pericardi
effus
otherwis
normal
abdomin
sonographi
establish
diagnosi
perimyocard
transthorac
echocardiogram
reveal
diffus
hypokinet
left
ventricl
nearnorm
leftventricular
eject
fraction
normal
confirm
presenc
small
pericardi
effus
without
haemodynam
relev
sign
rightventricular
dysfunct
pulmonari
hypertens
low
thyroidstimul
hormon
tsh
mul
normal
mul
increas
free
pmoll
normal
pmoll
normal
free
concentr
pmoll
normal
pmoll
compat
druginduc
hyperthyroid
possibl
contribut
tachycardia
persist
despit
mg
bisoprolol
given
oral
later
patient
volum
resuscit
transfer
intens
care
unit
heart
rhythm
monitor
becam
profoundli
hypox
intub
mechan
ventil
h
admiss
hospit
chest
xray
show
bilater
infiltr
figur
patient
system
inflammatori
respons
syndrom
necessit
pressur
support
norepinephrin
day
pneumonia
sever
index
low
point
howev
correspond
risk
class
ii
predict
mortal
simplifi
acut
physiolog
score
point
confirm
low
predict
mortal
extens
sampl
empir
antibiot
therapi
amoxicillinclavulan
acid
clarithromycin
start
later
switch
piperacillintazobactam
bronchoscopi
reveal
chronic
bronchiti
cytolog
analysi
bronchial
secret
show
abund
neutrophil
eosinophil
granulocyt
rna
sequenc
rhinoviru
could
amplifi
revers
transcript
pcr
three
differ
tracheal
secret
specimen
therefor
establish
diagnosi
sever
rhinovir
bilater
pneumonia
caus
acut
respiratori
distress
syndrom
ard
time
cours
horovitz
index
shown
figur
confirm
sever
lung
injuri
pneumonia
ct
chest
consist
diagnosi
ard
figur
sign
pulmonari
peliosi
follow
viral
infect
exclud
qualit
pcr
influenza
b
parainfluenza
respiratori
syncyti
cytomegali
adeno
boca
corona
entero
metapneumonia
parecho
virus
antibodi
respons
hantavirus
test
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
corona
virus
perform
bacteri
cultur
blood
urin
tracheal
secret
remain
steril
includ
taken
start
antibiot
therapi
antibodi
hiv
found
titr
antinuclear
antineutrophil
cytoplasm
antidoubl
stranddna
antibodi
neg
cours
ill
favour
ga
exchang
improv
time
c
reactiv
protein
concentr
diminish
figur
chest
xray
show
regress
opac
figur
patient
extub
day
four
day
later
transfer
ward
pulmonari
rehabilit
programm
start
hospit
stay
day
outpati
followup
visit
confirm
patient
well
resum
physic
train
session
rhinovirus
genet
compris
three
differ
group
b
c
belong
genu
enteroviru
picornavirida
famili
frequent
caus
upper
respiratori
tract
infect
includ
common
cold
account
approxim
case
incub
period
day
viral
shed
may
last
long
week
infect
may
occur
throughout
year
patient
asthma
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
high
risk
exacerb
case
rhinovir
infect
addit
rhinovirus
caus
lower
respiratori
tract
infect
especi
elderli
immunocompromis
host
use
revers
transcript
pcr
rhinovirus
repeatedli
found
respiratori
secret
patient
communityacquir
healthcareassoci
pneumonia
intens
care
unit
tabl
human
rhinoviru
detect
viru
posit
specimen
among
frequent
isol
virus
often
patient
rhinovir
pneumonia
sever
underli
diseas
includ
malign
tumour
immunosuppress
therefor
mortal
rhinovir
pneumonia
may
substanti
establish
treatment
prevent
strategi
rhinovir
pneumonia
human
human
rhinovirus
also
play
role
pathogenesi
pericard
particular
group
c
rhinovirus
report
caus
sever
lower
respiratori
tract
infect
haemorrhag
pericard
patient
rapidli
progress
sever
bilater
rhinovir
pneumonia
lead
develop
ard
necessit
airway
intub
mechan
ventil
intens
care
unit
smoke
habit
excess
physic
exercis
ingest
ped
neg
impact
immun
system
figur
smoker
pneumonia
three
time
like
admit
intens
care
unit
nonsmok
indic
sever
cours
ill
smoker
prone
strenuou
exercis
reduc
immunolog
defenc
mechan
may
increas
suscept
infect
review
ref
athlet
found
increas
incid
respiratori
tract
infect
intens
train
period
may
due
decreas
salivari
iga
product
moreov
exhaust
train
session
lower
neutrophil
tcell
lymphocyt
count
peripher
blood
therefor
may
compromis
innat
adapt
immun
function
ideal
athlet
highli
perform
bodi
easi
avail
aa
even
internet
without
prescript
physician
propag
use
among
elit
athlet
also
among
casual
fit
enthusiast
estim
preval
ped
use
among
member
fit
centr
netherland
known
sever
side
effect
includ
prematur
death
discourag
fit
aficionado
regular
intak
ped
aa
interlop
immun
system
manifold
way
howev
studi
exist
address
longterm
immunomodulatori
effect
exact
type
drug
use
dose
time
administr
often
remain
elus
pathogenet
role
ascrib
use
develop
sever
infect
includ
pneumonia
vitro
oxid
capac
neutrophil
granulocyt
reduc
androgen
steroid
neg
impact
phagocyt
function
moreov
antibodi
concentr
iga
igm
lower
bodybuild
use
aa
suggest
enhanc
risk
infect
nandrolon
increas
product
interleukin
tumour
necrosi
factor
human
peripher
blood
lymphocyt
interferon
product
human
cell
line
diminish
latter
may
jeopardis
antivir
respons
vivo
may
due
alter
helper
cell
function
androgen
steroid
addit
desir
effect
muscl
bone
function
may
import
pathogenet
role
pulmonari
diseas
support
airway
inflamm
fibrosi
thyroid
hormon
may
contribut
airway
smooth
muscl
remodel
certain
circumst
taken
togeth
immunomodulatori
effect
smoke
heavi
workout
chronic
ingest
ped
may
contribut
sever
pneumonia
patient
human
rhinovirus
caus
sever
pneumonia
includ
develop
acut
respiratori
distress
syndrom
viral
pneumonia
deterior
ga
exchang
necessit
intub
mechan
ventil
may
rapid
treatment
rhinovir
pneumonia
entir
support
consumpt
performanceenhanc
drug
probabl
immunomodulatori
effect
unusu
present
common
diseaseinjuri
copyright
bmj
publish
group
right
reserv
permiss
reus
content
visit
http
groupbmjcomgrouprightslicensingpermiss
bmj
case
report
fellow
may
reus
articl
person
use
teach
without
permiss
